Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants
NCT03381664
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Adult Male and Female Volunteers
Interventions
DRUG:
AVP-923
Sponsor
Avanir Pharmaceuticals